>
Small Pharma Inc logo

DMT - Small Pharma Inc Share Price

C$0.385 0.0  0.0%

Last Trade - 23/09/21

Sector
Healthcare
Size
Market Cap £0.22
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 2705
Bullish
Bearish
Unlock DMT Revenue
Momentum
Relative Strength (%)
1m +0.91%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -65.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 01st Jan 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : Small Pharma Inc has not disclosed any comparablefinancial information.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

DMT Revenue Unlock DMT Revenue

Net Income

DMT Net Income Unlock DMT Revenue

Normalised EPS

DMT Normalised EPS Unlock DMT Revenue

PE Ratio Range

DMT PE Ratio Range Unlock DMT Revenue

Dividend Yield Range

DMT Dividend Yield Range Unlock DMT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
DMT EPS Forecasts Unlock DMT Revenue
Profile Summary

Small Pharma Inc., formerly Unilock Capital Corp, is a Canada-based neuropharmaceutical company. The Company is specialized in development of treatments for mental health conditions, with a focus on depression. Small Pharma is focused on developing N,N-dimethyltryptamine (DMT) and a pipeline of patent-protected deuterium-enriched tryptamine compounds in combination with psychotherapy as potential rapid onset, sustained treatments for depression and other mental health disorders. The Company is progressing the development of DMT-assisted therapy, using its synthetic formulation, SPL026, alongside psychotherapy. Its pipeline also includes SPL028, SPL029 and SPL801B.

Directors
Last Annual January 1st, 1970
Last Interim January 1st, 1970
Incorporated January 23, 2018
Public Since November 16, 2018
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange TSX Venture Exchange
Shares in Issue
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
DMT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for DMT
Upcoming Events for DMT
Frequently Asked Questions for Small Pharma Inc
What is the Small Pharma Inc share price?

As of 23/09/21, shares in Small Pharma Inc are trading at C$0.385, giving the company a market capitalisation of £0.22. This share price information is delayed by 15 minutes.

How has the Small Pharma Inc share price performed this year?

Shares in Small Pharma Inc are currently trading at C$0.385 and the price has moved by -40.22% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Small Pharma Inc price has moved by -53.37% over the past year.

What are the analyst and broker recommendations for Small Pharma Inc?

There are no analysts currently covering Small Pharma Inc.

When will Small Pharma Inc next release its financial results?

It is not known when Small Pharma Inc will next release financial results.

What is the Small Pharma Inc dividend yield?

Small Pharma Inc does not currently pay a dividend.

Does Small Pharma Inc pay a dividend?

Small Pharma Inc does not currently pay a dividend.

When does Small Pharma Inc next pay dividends?

Small Pharma Inc does not currently pay a dividend.

How do I buy Small Pharma Inc shares?

To buy shares in Small Pharma Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Small Pharma Inc?

Shares in Small Pharma Inc are currently trading at C$0.385, giving the company a market capitalisation of £0.22.

Where are Small Pharma Inc shares listed? Where are Small Pharma Inc shares listed?

Here are the trading details for Small Pharma Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: DMT
What kind of share is Small Pharma Inc?

We were not able to load our ranking data for Small Pharma Inc

Is there a Small Pharma Inc share price forecast 2021?

We were not able to load any forecast data for Small Pharma Inc.

How can I tell whether the Small Pharma Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Small Pharma Inc. Over the past six months, the relative strength of its shares against the market has been -48.8%. At the current price of C$0.385, shares in Small Pharma Inc are trading at -23.53% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Small Pharma Inc PE Ratio?

We were not able to find PE ratio data for Small Pharma Inc.

Who are the key directors of Small Pharma Inc?

We were unable to find the directors for Small Pharma Inc.

Who are the major shareholders of Small Pharma Inc?

Here are the top five shareholders of Small Pharma Inc based on the size of their shareholding:

Rands (Peter David) Individual Investor
Percentage owned: 28.67% (91.1m shares)
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund
Percentage owned: 2.41% (7.66m shares)
Biotech Growth Trust PLC Mutual Fund
Percentage owned: 2.41% (7.66m shares)
Tziras (George) Individual Investor
Percentage owned: 1.02% (3.23m shares)
Layzell (Marie) Individual Investor
Percentage owned: 0.91% (2.89m shares)
Similar to DMT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.